Suppr超能文献

非瓣膜性心房颤动日本患者中 HELT-ES 评分的外部验证——RAFFINE 和 SAKURA 注册研究的汇总分析。

External Validation of the HELT-ES Score in Japanese Patients With Nonvalvular Atrial Fibrillation - A Pooled Analysis of the RAFFINE and SAKURA Registries.

机构信息

Nihon University School of Medicine.

Division of Cardiology, Nihon University Itabashi Hospital.

出版信息

Circ J. 2023 Nov 24;87(12):1777-1787. doi: 10.1253/circj.CJ-23-0318. Epub 2023 Aug 9.

Abstract

BACKGROUND

The HELT-ESscore, which assigns 1 point to Hypertension, Elderly aged 75-84 years, Low body mass index <18.5 kg/m, and Type of atrial fibrillation (AF: persistent/permanent), and 2 points to Extreme Elderly aged ≥85 years and previous Stroke, has been proposed as a new risk stratification for strokes in Japanese AF patients, but has not yet undergone external validation.

METHODS AND RESULTS

We evaluated the prognostic performance of the HELT-ESscore for stroke risk stratification using 2 large-scale registries in Japanese AF patients (n=7,020). During 23,241 person-years of follow-up (mean follow-up 1,208±450 days), 287 ischemic stroke events occurred. The C-statistic using the HELT-ESscore was 0.661 (95% confidence interval [CI], 0.629-0.692), which was numerically higher than with the CHADSscore (0.644, 95% CI 0.613-0.675; P=0.15 vs. HELT-ES) or CHADS-VASc score (0.650, 95% CI, 0.619-0.680; P=0.37 vs. HELT-ES). In the SAKURA AF Registry, the C-statistic of the HELT-ESscore was consistently higher than the CHADSand CHADS-VASc scores across all 3 types of facilities comprising university hospitals, general hospitals, and clinics. However, in the RAFFINE Study, its superiority was only observed in general hospitals.

CONCLUSIONS

The HELT-ESscore demonstrated potential value for risk stratification, particularly in a super-aged society such as Japan. However, its superiority over the CHADSor CHADS-VASc scores may vary across different hospital settings.

摘要

背景

HELT-ES 评分将高血压、年龄在 75-84 岁的老年人、低体重指数<18.5kg/m2 和心房颤动(AF:持续性/永久性)的类型赋值为 1 分,将极高龄(≥85 岁)和既往卒中的患者赋值为 2 分,用于对日本 AF 患者的卒中风险进行分层,但尚未经过外部验证。

方法和结果

我们使用日本 AF 患者的两个大型登记处(n=7020)评估了 HELT-ES 评分对卒中风险分层的预后性能。在 23241 人年的随访期间(平均随访 1208±450 天),发生了 287 例缺血性卒中事件。HELT-ES 评分的 C 统计量为 0.661(95%置信区间[CI]:0.629-0.692),略高于 CHADS 评分(0.644,95%CI 0.613-0.675;P=0.15 与 HELT-ES 相比)或 CHADS-VASc 评分(0.650,95%CI,0.619-0.680;P=0.37 与 HELT-ES 相比)。在 SAKURA AF 登记处,HELT-ES 评分的 C 统计量在大学医院、综合医院和诊所三种类型的医疗机构中均高于 CHADS 和 CHADS-VASc 评分。然而,在 RAFFINE 研究中,仅在综合医院观察到其优越性。

结论

HELT-ES 评分在日本这样的超老龄化社会中具有潜在的风险分层价值。然而,其与 CHADS 或 CHADS-VASc 评分相比的优越性可能因不同的医院环境而异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验